Renvela, comprimé pelliculé - 180 Tablette(n) Swissmedic Key 61648001 Registration Holder Sanofi-Aventis (Suisse) SA Name Renvela, comprimé pelliculé Date of registration 10.11.2011 Original/Generic Original Introduction of Sequence 10.11.2011 ATC-Classification Sevelamer (V03AE02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.99. Show package size 180 Tablette(n) Index Therapeuticus (Swissmedic) 07.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 141.67 Limitation Yes Limitation text
Deductible 10 % Consumer price 179.20 Feedback FB Daily cost GTIN 7680616480019 Medication Code Synthetika Pharmacode 5081204 Disponibility
Composition sevelameri carbonas 800 mg, natrii chloridum corresp. natrium 1.26 mg, cellulosum microcristallinum, zinci stearas, pellicule: hypromellosum, monoglyceriderorum diacetylates, encre: hypromellosum, propylenglycolum, E 172 (nigrum), pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Sevelameri Carbonas 800 mg
BAG: Active Agent Dose Sevelameri Carbonas 800 mg
Inactive agents additional_information (Nigrum) Cellulosum Microcristallinum E 172 color. Hypromellosum encre Monoglyceriderorum Diacetylates Sodium Chloride Pro Compresso Obducto Propylenglycol Zinc Stearate
Source Data was imported : 08.08.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
